BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 4, Issue 1 , Pages 7-16 , January 2011

Electrodes in the brain—Ethical criteria for research and treatment with deep brain stimulation for neuropsychiatric disorders

  • Matthis Synofzik

      Affiliations

    • Department for Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Germany
    • ,
  • Thomas E. Schlaepfer

      Affiliations

    • Department of Psychiatry and Psychotherapy, University Hospital, Bonn, Germany
    • Departments of Psychiatry and Mental Health, The Johns Hopkins University, Baltimore, Maryland
    • Corresponding Author InformationCorrespondence: Thomas E. Schlaepfer, MD, Department of Psychiatry/University Hospital, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany.

Received 27 July 2009 ,Revised 12 January 2010 ,Accepted 14 January 2010.

References 

  1. Perlmutter JS, Mink JW. Deep brain stimulation. Annu Rev Neurosci. 2006;2:2229–2257
  2. Abelson JL, Curtis GC, Sagher O, et al. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry. 2005;57(5):510–516
  3. Greenberg BD, Malone DA, Friehs GM, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006;31(11):2394
  4. Nuttin BJ, Gabriels LA, Cosyns PR, et al. Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery. 2003;52(6):1263–1272discussion 1272–1274
  5. Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008;359(20):2121–2134
  6. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2008;64(6):461–467
  7. Malone DA, Dougherty DD, Rezai AR, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry. 2008;65:267–275
  8. Schlaepfer TE, Cohen MX, Frick C, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33(2):368–377
  9. Goodman WK, Insel TR. Deep brain stimulation in psychiatry: concentrating on the road ahead. Biol Psychiatry. 2009;65(4):263–266
  10. Advanced Neuromodulation Systems (ANS) Inc. BROADEN Clinical study. A Study of a non-pharmacological device for depression. 2007 [cited 2009 01/06]; Available from: http://www.broadenstudy.com/sb/index.html
  11. Medtronic Inc. Medtronic to pursue major clinical trial of deep brain stimulation as depression treatment. 2006 [cited 2009 01/06]; Available from: http://findarticles.com/p/articles/mi_m0EIN/is_2006_April_25/ai_n26838044?tag=content-inner;col1
  12. Synofzik M, Schlaepfer TE. Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. Biotechnol J. 2008;3(12):1511–1520
  13. Ford PJ. Neurosurgical implants: clinical protocol considerations. Camb Q Healthc Ethics. 2007;16(3):308–311
  14. Fins JJ. A leg to stand on: Sir William Osler and Wilder Penfield's “neuroethics”. Am J Bioeth. 2008;8(1):37–46
  15. Kubu CS, Ford PJ. Ethics in the clinical application of neural implants. Camb Q Healthc Ethics. 2007;16(3):317–321
  16. Glannon W. Stimulating brains, altering minds. J Med Ethics. 2009;35(5):289–292
  17. Farris SM, Gianola FJ. Ethical issues surrounding deep brain stimulation in Parkinson's disease. JAAPA. 2009;22(2):57–58
  18. Kringelbach ML, Aziz TZ. Deep brain stimulation: avoiding the errors of psychosurgery. JAMA. 2009;301(16):1705–1707
  19. Farris S, Ford P, DeMarco J, Giroux ML. Deep brain stimulation and the ethics of protection and caring for the patient with Parkinson's dementia. Mov Disord. 2008;23(14):1973–1976
  20. Schiff ND, Giacino JT, Fins JJ. Deep brain stimulation, neuroethics, and the minimally conscious state: moving beyond proof of principle. Arch Neurol. 2009;66(6):697–702
  21. Rabins P, Appleby BS, Brandt J, et al. Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Arch Gen Psychiatry. 2009;66(9):931–937
  22. Racine E, Waldman S, Palmour N, Risse D, Illes J. Currents of hope: neurostimulation techniques in U.S. and U.K. print media. Camb Q Healthc Ethics. 2007;16(3):312–316
  23. Bell E, Mathieu G, Racine E. Preparing the ethical future of deep brain stimulation. Surg Neurol. 2009;72:577–586discussion 586
  24. Glannon W. Neurostimulation and the minimally conscious state. Bioethics. 2008;22(6):337–345
  25. Miller G. Neuropsychiatry: rwiring faulty circuits in the brain. Science. 2009;323(5921):1554–1556
  26. Hildt E. Electrodes in the brain: Some anthropological and ethical aspects of deep brain stimulation. Int Rev Information Ethics. 2006;5(9):33–39
  27. Beauchamp T, Childress J. Principles of biomedical ethics. 6th ed.. New York: Oxford University Press; 2008;
  28. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651–660
  29. Greenberg BD, Malone DA, Friehs GM, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006;31(11):2384–2393
  30. Kuhn J, Bauer R, Pohl S, et al. Observations on unaided smoking cessation after deep brain stimulation of the nucleus accumbens. Eur Addict Res. 2009;15(4):196–201
  31. Kuhn J, Lenartz D, Huff W, et al. Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications?. J Neurol Neurosurg Psychiatry. 2007;78(10):1152–1153
  32. Franzini A, Marras C, Ferroli P, Bugiani O, Broggi G. Stimulation of the posterior hypothalamus for medically intractable impulsive and violent behavior. Stereotact Funct Neurosurg. 2005;83(2-3):63–66
  33. Kuhn J, Lenartz D, Mai JK, Huff W, Klosterkoetter J, Sturm V. Disappearance of self-aggressive behavior in a brain-injured patient after deep brain stimulation of the hypothalamus: technical case report. Neurosurgery. 2008;62(5):E1182;discussion E1182
  34. Schlaepfer TE, Lieb K. Deep brain stimulation for treatment of refractory depression. Lancet. 2005;366(9495):1420–1422
  35. Mesnage V, Houeto JL, Welter ML, et al. Parkinson's disease: neurosurgery at an earlier stage?. J Neurol Neurosurg Psychiatry. 2002;73(6):778–779
  36. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain. 2002;125(Pt 3):575–583
  37. Schupbach WM, Maltete D, Houeto JL, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology. 2007;68(4):267–271
  38. Isaias IU, Alterman RL, Tagliati M. Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration. Brain. 2008;131(Pt 7):1895–1902
  39. Synofzik M. [Effective, indicated - and yet without benefit? The goals of dementia drug treatment and the well-being of the patient.]. Z Gerontol Geriatr. 2006;39(4):301–307
  40. Schupbach M, Gargiulo M, Welter ML, et al. Neurosurgery in Parkinson disease: a distressed mind in a repaired body?. Neurology. 2006;66(12):1811–1816
  41. Agid Y, Schupbach M, Gargiulo M, et al. Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so?. J Neural Transm Suppl. 2006;(70):409–414
  42. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355(9):896–908
  43. Kupsch A, Benecke R, Muller J, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med. 2006;355(19):1978–1990
  44. Bewernick BH, Hurlemann R, Matusch A, et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry. 2010;67(2):110–116
  45. Keller MB, Hirschfeld RM, Demyttenaere K, Baldwin DS. Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol. 2002;17(6):265–271
  46. Nutt DJ, Sharpe M. Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. J Psychopharmacol. 2008;22(1):3–6
  47. Kenney C, Simpson R, Hunter C, et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg. 2007;106(4):621–625
  48. Elliott C. Caring about risks. Are severely depressed patients competent to consent to research?. Arch Gen Psychiatry. 1997;54(2):113–116
  49. Bursztajn HJ, Harding HP, Gutheil TG, Brodsky A. Beyond cognition: the role of disordered affective states in impairing competence to consent to treatment. Bull Am Acad Psychiatry Law. 1991;19(4):383–388
  50. Grimes AL, McCullough LB, Kunik ME, Molinari V, Workman RH. Informed consent and neuroanatomic correlates of intentionality and voluntariness among psychiatric patients. Psychiatr Serv. 2000;51(12):1561–1567
  51. Rudnick A. Depression and competence to refuse psychiatric treatment. J Med Ethics. 2002;28(3):151–155
  52. Herzog J, Reiff J, Krack P, et al. Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease. Mov Disord. 2003;18(11):1382–1384
  53. Mandat TS, Hurwitz T, Honey CR. Hypomania as an adverse effect of subthalamic nucleus stimulation: report of two cases. Acta Neurochir (Wien). 2006;148(8):895–897discussion 898
  54. Raucher-Chene D, Charrel CL, de Maindreville AD, Limosin F. Manic episode with psychotic symptoms in a patient with Parkinson's disease treated by subthalamic nucleus stimulation: improvement on switching the target. J Neurol Sci. 2008;273(1-2):116–117
  55. Okun MS, Mann G, Foote KD, et al. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry. 2007;78(3):310–314
  56. Okun MS, Bowers D, Springer U, et al. What's in a “smile?” Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase. 2004;10(4):271–279
  57. Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA. 1992;267(16):2221–2226
  58. Nuttin B, Gybels J, Cosyns P, et al. Deep brain stimulation for psychiatric disorders. Neurosurgery. 2002;51(2):519
  59. Fins JJ, Rezai AR, Greenberg BD. Psychosurgery: avoiding an ethical redux while advancing a therapeutic future. Neurosurgery. 2006;59(4):713–716
  60. Ford PJ, Kubu CS. Stimulating debate: ethics in a multidisciplinary functional neurosurgery committee. J Med Ethics. 2006;32(2):106–109
  61. Diamond A. Problems with deep brain stimulation devices referred to private practice for follow up. Parkinsonism Relat Disord. 2007;13(8):520–523
  62. Dickersin K, Rennie D. Registering clinical trials. JAMA. 2003;290(4):516–523
  63. Videnovic A, Metman LV. Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Mov Disord. 2008;23(3):343–349
  64. Voges J, Hilker R, Botzel K, et al. Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord. 2007;22(10):1486–1489
  65. Funkiewiez A, Ardouin C, Krack P, et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord. 2003;18(5):524–530
  66. Shapira NA, Okun MS, Wint D, et al. Panic and fear induced by deep brain stimulation. J Neurol Neurosurg Psychiatry. 2006;77(3):410–412
  67. Piasecki SD, Jefferson JW. Psychiatric complications of deep brain stimulation for Parkinson's disease. J Clin Psychiatry. 2004;65(6):845–849
  68. Drapier D, Drapier S, Sauleau P, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?. J Neurol. 2006;253(8):1083–10891
  69. Richard IH. Depression and apathy in Parkinson's disease. Curr Neurol Neurosci Rep. 2007;7(4):295–301
  70. Smeding HM, Speelman JD, Koning-Haanstra M, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology. 2006;66(12):1830–1836
  71. Carmichael ST, Price JL. Connectional networks within the orbital and medial prefrontal cortex of macaque monkeys. J Comp Neurol. 1996;371(2):179–207
  72. Appleby BS, Duggan PS, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov Disord. 2007;22(12):1722–1728
  73. Kapoor S. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2009;360(9):931–932author reply 932
  74. Soulas T, Gurruchaga JM, Palfi S, Cesaro P, Nguyen JP, Fenelon G. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008;79(8):952–954
  75. Torres AR, Prince MJ, Bebbington PE, et al. Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry. 2006;163(11):1978–1985

 Dr. Schlaepfer received limited support for an Investigator Initiated Study on DBS in resistant major depression from Medtronic Inc, a manufacturer of DBS equipment between 2004 and 2007.

PII: S1935-861X(10)00020-3

doi: 10.1016/j.brs.2010.03.002

BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 4, Issue 1 , Pages 7-16 , January 2011

Article Tools

* Image Usage & Resolution